Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus multilocularis | pyruvate kinase | 0.0032 | 0.3035 | 0.3035 |
Trypanosoma brucei | pyruvate kinase 1, putative | 0.0032 | 0.3035 | 0.5 |
Echinococcus multilocularis | pyruvate kinase | 0.0032 | 0.3035 | 0.3035 |
Brugia malayi | Pyruvate kinase, M2 isozyme | 0.0032 | 0.3035 | 0.1843 |
Loa Loa (eye worm) | sema domain-containing protein | 0.0024 | 0.1462 | 0.0354 |
Giardia lamblia | Pyruvate kinase | 0.0032 | 0.3035 | 1 |
Plasmodium vivax | pyruvate kinase, putative | 0.0032 | 0.3035 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0034 | 0.3295 | 0.4141 |
Onchocerca volvulus | Pyruvate kinase homolog | 0.0032 | 0.3035 | 0.2422 |
Brugia malayi | Pyruvate kinase, muscle isozyme | 0.0032 | 0.3035 | 0.1843 |
Schistosoma mansoni | hypothetical protein | 0.0024 | 0.1462 | 0.1837 |
Onchocerca volvulus | Pyruvate kinase homolog | 0.0032 | 0.3035 | 0.2422 |
Brugia malayi | Plexin repeat family protein | 0.0058 | 0.7957 | 0.7608 |
Toxoplasma gondii | pyruvate kinase PyK1 | 0.0032 | 0.3035 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0058 | 0.7957 | 0.7692 |
Echinococcus granulosus | semaphorin 5B | 0.0024 | 0.1462 | 0.1462 |
Plasmodium falciparum | pyruvate kinase | 0.0032 | 0.3035 | 1 |
Trypanosoma cruzi | pyruvate kinase 2, putative | 0.0032 | 0.3035 | 0.5 |
Echinococcus granulosus | pyruvate kinase | 0.0032 | 0.3035 | 0.3035 |
Loa Loa (eye worm) | pyruvate kinase | 0.0032 | 0.3035 | 0.2132 |
Echinococcus multilocularis | pyruvate kinase | 0.0026 | 0.1721 | 0.1721 |
Echinococcus granulosus | semaphorin 1A | 0.0024 | 0.1462 | 0.1462 |
Schistosoma mansoni | plexin | 0.0058 | 0.7957 | 1 |
Echinococcus multilocularis | hypothetical protein | 0.0024 | 0.1462 | 0.1462 |
Loa Loa (eye worm) | hypothetical protein | 0.0024 | 0.1462 | 0.0354 |
Loa Loa (eye worm) | sema domain-containing protein | 0.0024 | 0.1462 | 0.0354 |
Loa Loa (eye worm) | hypothetical protein | 0.0024 | 0.1462 | 0.0354 |
Leishmania major | pyruvate kinase | 0.0032 | 0.3035 | 0.5 |
Trypanosoma brucei | pyruvate kinase 1 | 0.0032 | 0.3035 | 0.5 |
Loa Loa (eye worm) | pyruvate kinase | 0.0032 | 0.3035 | 0.2132 |
Mycobacterium leprae | Probable pyruvate kinase PykA | 0.0032 | 0.3035 | 0.5 |
Echinococcus multilocularis | plexin a4 | 0.0068 | 1 | 1 |
Trypanosoma cruzi | pyruvate kinase 2, putative | 0.0032 | 0.3035 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0024 | 0.1462 | 0.0354 |
Loa Loa (eye worm) | hypothetical protein | 0.0024 | 0.1462 | 0.0354 |
Entamoeba histolytica | pyruvate kinase, putative | 0.0023 | 0.1148 | 0.5 |
Onchocerca volvulus | Pyruvate kinase homolog | 0.0032 | 0.3035 | 0.2422 |
Loa Loa (eye worm) | plexin A | 0.0068 | 1 | 1 |
Onchocerca volvulus | 0.0058 | 0.7957 | 1 | |
Loa Loa (eye worm) | hypothetical protein | 0.0034 | 0.3295 | 0.2425 |
Mycobacterium tuberculosis | Probable pyruvate kinase PykA | 0.0032 | 0.3035 | 0.5 |
Schistosoma mansoni | pyruvate kinase | 0.0032 | 0.3035 | 0.3814 |
Loa Loa (eye worm) | hypothetical protein | 0.0024 | 0.1462 | 0.0354 |
Chlamydia trachomatis | pyruvate kinase | 0.0032 | 0.3035 | 0.5 |
Schistosoma mansoni | plexin | 0.0034 | 0.3295 | 0.4141 |
Schistosoma mansoni | pyruvate kinase | 0.0032 | 0.3035 | 0.3814 |
Schistosoma mansoni | semaphorin 5-related | 0.0024 | 0.1462 | 0.1837 |
Loa Loa (eye worm) | hypothetical protein | 0.0032 | 0.3035 | 0.2132 |
Leishmania major | pyruvate kinase | 0.0032 | 0.3035 | 0.5 |
Mycobacterium ulcerans | pyruvate kinase | 0.0032 | 0.3035 | 0.5 |
Trichomonas vaginalis | pyruvate kinase, putative | 0.0032 | 0.3035 | 0.5 |
Echinococcus granulosus | pyruvate kinase | 0.0032 | 0.3035 | 0.3035 |
Echinococcus multilocularis | semaphorin 5B | 0.0024 | 0.1462 | 0.1462 |
Loa Loa (eye worm) | pyruvate kinase | 0.0032 | 0.3035 | 0.2132 |
Loa Loa (eye worm) | hypothetical protein | 0.0024 | 0.1462 | 0.0354 |
Trichomonas vaginalis | pyruvate kinase, putative | 0.0032 | 0.3035 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0024 | 0.1462 | 0.1837 |
Echinococcus granulosus | plexin a4 | 0.0068 | 1 | 1 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.